Study has suggested that CD96 could synergize with TIGIT to inhibit the antitumor response in tumor-bearing mouse models with lung metastasis, as the antitumor effect of CD96 blockade is higher in Tigit−/− mice (8). This evidence concerns the gene CD96 and neoplasm.